Mallinckrodt shares drop after U.S. joins cases over expensive drug
Mallinckrodt shares drop after U.S. joins cases over expensive drug
The U.S. Justice Department has joined a pair of whistleblower lawsuits alleging a drugmaker now owned by Mallinckrodt Plc improperly promoted an expensive multiple sclerosis treatment and paid kickbacks to doctors who prescribed the drug.
from Reuters: Health https://reut.rs/2GUGDFn
via Blogger http://bit.ly/2vxgTIs
May 01, 2019 at 12:35PM
The U.S. Justice Department has joined a pair of whistleblower lawsuits alleging a drugmaker now owned by Mallinckrodt Plc improperly promoted an expensive multiple sclerosis treatment and paid kickbacks to doctors who prescribed the drug.
from Reuters: Health https://reut.rs/2GUGDFn
via Blogger http://bit.ly/2vxgTIs
May 01, 2019 at 12:35PM
No comments